Avacta Group PLC (AVCT)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
70.00p
Buy
72.00p
2.50p (+3.65%)
Prices updated at 12 Jun 2026, 16:28 BST
| Prices minimum 15 mins delay
Prices in GBX
Avacta Group PLC is a clinical-stage life sciences company expanding the reach of potent cancer therapies with the pre-CISION platform. pre-CISION is a proprietary warhead delivery system based on a tumor-specific protease (fibroblast activation prote ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
01 Jun 202629 May 202613 May 202613 May 202606 May 202621 Apr 202614 Apr 202609 Apr 202608 Apr 202631 Mar 2026
Key dates
| Forecast date | |
|---|---|
| Annual report | May 2027 |
| Final results | May 2027 |
| Half yearly results | Sep 2026 |
| Annual general meeting | Jun 2026 |
| Previous date | |
|---|---|
| Annual report | May 2026 |
| Final results | May 2026 |
| Half yearly results | Sep 2025 |
| Annual general meeting | Jul 2025 |
Company reports
31 Dec 2025
Annual Report 30 Jun 2025
Quarterly Report 